Bionpharma endeavors to bring quality generics to the market across therapeutic areas. For doing so we constantly evaluate products that can add value to all stake holders and the health‐Care system. This enables us to work on the development of these products and put them through the FDA approval process. Bionpharma is engaged In product development in different geographies across the World.

OTC products NDAs & ANDAs

Active Ingredient

  • CETIRIZINE HYDROCHLORIDE
  • CETIRIZINE HYDROCHLORIDE
  • CETIRIZINE HYDROCHLORIDE
  • CETIRIZINE HYDROCHLORIDE
  • DIPHENHYDRAMINE IBUPROFEN
  • IBUPROFEN

  • IBUPROFEN
  • NAPROXEN SODIUM
  • LOPERAMIDE HYDROCHLORIDE
  • LOPERAMIDE HYDROCHLORIDE

Dosage Form

  • CAPSULE;ORAL

  • CAPSULE;ORAL

  • CAPSULE;ORAL

  • CAPSULE;ORAL

  • CAPSULE;ORAL

  • CAPSULE;ORAL

  • CAPSULE;ORAL
  • CAPSULE;ORAL
  • CAPSULE;ORAL

  • CAPSULE;ORAL

Strength

  • 10MG

  • 5MG

  • 10MG

  • 5MG

  • 25MG; 200MG

  • EQ 200MG FREE ACID AND POTASSIUM SALT
  • 200MG
  • 220MG
  • 1MG

  • 2MG

 

© 2015 All Right Reseved Bionpharma
HOME | ABOUT | PRODUCTS | PARTNERSHIP | CONSUMER INFORMATION | NEWS | TERMS OF USE | DISCLAIMER | CONTACT